SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000909661-07-000070
Filing Date
2007-06-25
Accepted
2007-06-25 17:29:44
Documents
1
Group Members
CHUN R. DINGDAVID I. COHENDEREK C. SCHRIERDOUGLAS M. MACMAHONFARALLON CAPITAL INSTITUTIONAL PARTNERS II, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.FARALLON CAPITAL OFFSHORE INVESTORS II, L.P.FARALLON

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D FOR BIOMET biomet13d.htm SC 13D 1046514
  Complete submission text file 0000909661-07-000070.txt   1049523
Mailing Address 56 E BELL DRIVE P O BOX 587 WARSAW IN 46581-0587
Business Address 56 EAST BELL DR WARSAW IN 46582 5742676639
BIOMET INC (Subject) CIK: 0000351346 (see all company filings)

IRS No.: 351418342 | State of Incorp.: IN | Fiscal Year End: 0531
Type: SC 13D | Act: 34 | File No.: 005-34815 | Film No.: 07939626
SIC: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies

Mailing Address ONE MARITIME PLAZA SUITE 2100 SAN FRANCISCO CA 94111
Business Address ONE MARITIME PLAZA SUITE 2100 SAN FRANCISCO CA 94111 (415)421-2132
FARALLON CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000909661 (see all company filings)

IRS No.: 943240279
Type: SC 13D